Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alvocidib in previously treated CLL/PLL
NCT00464633Phase 2Completed
- Sponsor
- Sanofi
- Start
- Mar 2007
- Primary completion
- Dec 2011
- Modality
- Orthosteric Ligands
- Countries
- 9
01
Overview
A Phase 2 trial of alvocidib in chronic lymphocytic leukemia (CLL), prolymphocytic leukemia (PLL), sponsored by Sanofi. Started Mar 2007; status: completed.
02
Drugs
alvocidib
03
Conditions
chronic lymphocytic leukemia (CLL)prolymphocytic leukemia (PLL)
Beyond the preview
Go deeper on NCT00464633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00464633.